NEW YORK ( TheStreet) -- Jim Cramer likes the growth-oriented as well as the yield-oriented Big Pharma stocks, he told Nicole Urken, "Mad Money's" research associate, Monday. "The international investor who is looking for a home will want to find yield and will want to find safety."One thing the big-cap pharma companies have done is to return money to shareholders, Cramer said. "They're all about bringing out values. Pfizer Pfizer (PFE - Get Report) has done a series of gigantic moves to bring out value."
'Mad Money' Uncovered: Big Pharma on a Down Day in the Market
Check Out Our Best Services for Investors
Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
Every recommendation goes through 3 layers of intense scrutinyquantitative, fundamental and technical analysisto maximize profit potential and minimize risk.
More than 30 investing pros with skin in the game give you actionable insight and investment ideas.